Analysis of alcohols in blood/plasma

Importance of the Topic

Rapid and precise determination of alcohol levels in blood and plasma is crucial for forensic investigations, clinical toxicology, and workplace safety assessments. Volatile alcohols such as ethanol, methanol, and isopropanol pose health risks and legal consequences, necessitating reliable analytical methods capable of high throughput and low detection limits.

Objectives and Study Overview

This application study demonstrates a rapid gas chromatographic method for quantifying common blood alcohols using an Agilent CP-Sil 19 CB column. The goals include achieving baseline separation of five key analytes in under three minutes and establishing a simple sample preparation workflow that ensures accuracy and repeatability.

Methodology

Sample collection was performed in EDTA-treated tubes followed by centrifugation. A 530 µl aliquot of plasma was mixed with 20 µl of an internal standard solution (2-propanol) in a sealed headspace vial. After equilibration at 50 °C for three minutes, a portion of the headspace gas was injected into the chromatograph under split-flow conditions.

Instrumentation Used

Gas Chromatograph: Agilent GC with wide-bore inlet
Column: CP-Sil 19 CB, 0.53 mm × 25 m fused silica
Carrier Gas: Nitrogen
Injector Temperature: 220 °C (split flow)
Detector: Flame Ionization Detector at 200 °C
Headspace Sampler: Equilibration at 50 °C for 3 minutes

Main Results and Discussion

The optimized method achieved baseline separation of acetaldehyde, methanol, ethanol, acetone, and 2-propanol within a three-minute run time. Detection limits for methanol and ethanol were 0.3 g/L. Two test samples yielded ethanol concentrations of 0.22 g/L and 2.90 g/L, demonstrating the method’s dynamic range and quantitative reliability.

Benefits and Practical Applications

• High throughput analysis with sub-three-minute run times reduces laboratory turnaround.
• Simple headspace sample preparation minimizes matrix interferences.
• Wide linear range and low detection limits support clinical, forensic, and industrial monitoring.

Future Trends and Potential Applications

• Coupling with mass spectrometry for enhanced selectivity and identification of additional volatile compounds.
• Automation of headspace sampling to further increase laboratory efficiency.
• Method adaptation for other biological matrices such as urine or breath condensate.

Conclusion

The presented GC-FID method offers a fast, robust, and reliable approach for alcohol analysis in blood/plasma. Its simplicity and performance make it suitable for routine forensic and clinical toxicology laboratories.

References

• Agilent Technologies, Application Note A01323: Analysis of Alcohols in Blood/Plasma, 2010.
• Kleppestö R., Clinical Pharmacology and Toxicology, University Hospital Dijkzigt, Rotterdam.